Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors
US6623962B1 · kind B1 · utility
17Cited by
4References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 1999 |
| Grant date | Sep 23, 2003 |
| Priority date | — |
| Expiry date | Sep 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enzymatic nucleic acid molecules which cleave EGFR RNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.